| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 6 Feb 25 | ELVN Enliven Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 22.47 | 23,014 | 517.12 k | 23,014 |
| 2 Jan 25 | ORIC ORIC Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 8.26 | 35,000 | 289.10 k | 35,000 |
| 18 Oct 24 | ELVN Enliven Therapeutics | Common Stock | Sell | Dispose S | Yes | Yes | 30.0021 | 753 | 22.59 k | 27,165 |
| 18 Oct 24 | ELVN Enliven Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 30.003 | 817 | 24.51 k | 123,673 |
| 15 Oct 24 | ELVN Enliven Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 27.6719 | 1,270 | 35.14 k | 124,490 |
| 4 Oct 24 | ELVN Enliven Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 27.5057 | 2,825 | 77.70 k | 125,760 |
